Jeffrey W. Albers, Director: Spyre Therapeutics SYRE Planned sale · Filed 08/07

Trade details

Type: Planned sale notice
Stock: Spyre Therapeutics SYRE
Person: Jeffrey W. AlbersDirector
Planned sale date: 26/08/07
Filed: 26/08/07

$517.1K to be sold

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 07/08~09/06

Jeffrey W. Albers's recent trades

Jeffrey W. AlbersDirector
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 plan
Spyre Therapeutics
SYRE
$1.9M
18,000 sh
$1.9M
Filed 08/07
Traded 08/07
Jeffrey W. AlbersDirector
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$245.5K
2,748 sh
$245.5K
Filed 25/12/08
Traded 25/12/08
Jeffrey W. AlbersDirector
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$203.4K
2,252 sh
$203.4K
Filed 25/12/08
Traded 25/12/08
Jeffrey W. AlbersDirector
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$333.1K
5,000 sh
$333.1K
Filed 25/12/08
Traded 25/12/08
Jeffrey W. AlbersDirector
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$296K
5,000 sh
$296K
Filed 25/10/14
Traded 25/10/13

Jeffrey W. Albers, Director — plans to sell 5,000 sh of Spyre Therapeutics SYRE · $517.1K · around 08/07 · 10b5-1 plan | Whalegun